Endovascular Treatment Devices Market Exclusive Trends Analysis with Forecast to 2031

The newly published report titled "Global Endovascular Treatment Devices Market (Product (percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices), Procedure (Ballon Angioplasty, Angioplasty With Stent Replacement, Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery, Thrombosis, Renal Artery Angioplasty and Stenting, Transfemoral Carotid Artery Revascularization, Intravascular Brachytherapy, Carotid Artery Stenting), Application (pulmonary, vascular, cardiology surgery, neurology and radiology))- By Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2031."

The Endovascular Treatment Devices Market Size is valued at 3.26 Billion in 2023 and is predicted to reach 6.54 Billion by the year 2031 at a 9.19% CAGR during the forecast period for 2024-2031.

Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1364

Endovascular surgery is a minimally invasive, technically sophisticated procedure that is employed to address medical conditions that affect the blood vessels, including aneurysms, bulging, or "ballooning" blood vessels. The treatment commences with a body incision to facilitate the passage of blood vessels. Then, a flexible plastic tube, stents, or catheter is inserted into the injured blood vessel to facilitate the withdrawal or delivery of medication from the patient's circulation. Intravenous antibiotic therapy, chemotherapy, blood transfusions, and long-term intravenous nutrition are among the therapies that utilize endovascular therapeutic devices.

It is anticipated that the market for endovascular treatment devices will expand during the forecast period as a result of factors such as an aging population, an increase in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased spending on research and development by market players. The high cost of endovascular procedures, a lack of knowledge in developing economies, and a shortage of qualified surgeons to perform the necessary functions are all factors that are impeding market expansion. The utilization of endovascular treatment devices has increased as a consequence of the increasing expenditure on healthcare and the introduction of innovative products, which is in turn fostering research and development.

List of Prominent Players in the Endovascular Treatment Devices Market:
• Japan Lifeline Co., Ltd.
• Medtronic
• Lombord Medical
• Cardinal Health
• Endospan
• Geting AB
• Bosten Scientific Corporation
• Inspire MD
• Penumbra, Inc.
• Terumo Corporation

Market Dynamics:
Drivers-
The high prevalence of abdominal aortic aneurysms, which are more prevalent in men, and a potential increase in demand for minimally invasive techniques such as endovascular surgery will also contribute to market growth in the coming years. According to screening studies, the prevalence of abdominal aortic aneurysms (AAA) is predominantly male, with a range of 4% to 8%. The prevalence of AAA is high in the ageing population and is expected to increase significantly in the future as a result of the expanding global geriatric population. The market for endovascular treatment devices will expand because of the significant improvements in minimally invasive surgery and the accelerated advancement of technology.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1364

Challenges:
The high cost of new endovascular therapy devices, a lack of awareness in economically underdeveloped countries, and the strict tax regulations on medical products in the United States are anticipated to be some of the primary obstacles in the global market for endovascular treatment devices.

Regional Trends:
The North American Endovascular Treatment Devices market is anticipated to experience substantial revenue growth and a high compound annual growth rate in the near future. The market has expanded as a result of the growing demand for these devices among medical professionals and the rise in the number of surgical operations. Consequently, major corporations have prioritized the development of state-of-the-art medical devices in these countries.

The obesity and diet epidemics, as well as the development of new products by prominent manufacturers, will drive the growth of the endovascular therapy devices market in the region. Furthermore, Asia Pacific possessed a substantial portion of the endovascular treatment devices market. The endovascular treatment devices market revenue growth in this region has been influenced by recent medical advancements, which has resulted in the industry's ongoing expansion. Growth can also be attributed to the increased R&D efforts and medical advancements made by significant participants in the region's nations.

Recent Developments:
• In November 2021, Endospan has provided safety and efficacy results for its off-the-shelf endovascular Nexus graft devices, which are intended to treat thoracic aortic lesions that involve the aortic arch. The results are available for both the 30-day and 1-year periods.
• In September 2021, Boston Scientific Corporation has reached an agreement to acquire Devoro Medical, the developer of the WOLF Thrombectomy Platform, in order to broaden its interventional techniques for thromboembolism, which include the EkoSonic Endovascular System.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1364

Segmentation of Endovascular Treatment Devices Market-
By Procedure-
• Ballon Angioplasty
• Angioplasty With Stent Replacement
• Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
• Thrombosis
• Renal Artery Angioplasty and Stenting
• Transfemoral Carotid Artery Revascularization
• Intravascular Brachytherapy
• Carotid Artery Stenting
By Product-
• Percutaneous Endovascular Aneurysm Repair (EVAR)
• Fenestrated EVAR
• Aortic Stents Biodegradable Stents
• Self-Expanding Nitinol Stents
• ThoracicAortic Aneurysm Grafts
• Other Devices
By Application-
• Pulmonary
• Vascular
• Cardiology Surgery
• Neurology
• Radiology
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Details insights on this market: https://www.insightaceanalytic.com/report/global-endovascular-treatment-devices-market-/1364

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email: info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.